Search Orphan Drug Designations and Approvals
-
Generic Name: | golimumab |
---|---|
Date Designated: | 05/21/2012 |
Orphan Designation: | Treatment of sarcoidosis |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 05/07/2014 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Janssen Biotech, Inc. 200 Great Vallley Parkway Malvern, Pennsylvania 19355 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-